Divi’s Laboratories board to approve unaudited financial results

27 Oct 2020 Evaluate

Divi’s Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 07/11/2020, to consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended 30 September, 2020. As intimated earlier, the Trading Window for dealing in securities of the Company has been closed from 01 October, 2020 till 48 hours after the declaration of financial results as per the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Divis Lab Share Price

6473.35 2.75 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×